Alkermes (ALKS) Non Operating Income (2010 - 2026)

Alkermes' (ALKS) quarterly Non Operating Income came in at -$13.6 million in Q1 2026, down 216.66% year-on-year from $11.7 million in Q1 2025, and down 700.35% on a QoQ basis from $2.3 million in Q4 2025.

Alkermes (ALKS) Non Operating Income (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Non Operating Income data on file, last reported at -$13.6 million in Q1 2026.

  • On a quarterly basis, Non Operating Income fell 216.66% year-over-year to -$13.6 million in Q1 2026; TTM through Mar 2026 was $12.2 million, a 61.06% decrease from a year earlier, with the FY2025 full-year figure at $37.5 million, up 62.21% from the prior year.
  • Non Operating Income for Q1 2026 stood at -$13.6 million, down from $2.3 million in the prior quarter.
  • Over the last five years, Non Operating Income for ALKS reached as high as $11.9 million in Q2 2025 and fell as low as -$18.4 million in Q1 2022.
  • Historically, Non Operating Income has averaged $1.7 million across 5 years, with a median of $3.5 million in 2023.
  • Across the five-year window, Non Operating Income plunged 729.04% in 2022 and jumped 1120.71% in 2024, its largest moves.
  • Year by year, Non Operating Income stood at -$1.1 million in 2022, then jumped by 433.18% to $3.7 million in 2023, then soared by 95.41% to $7.2 million in 2024, then sank by 68.43% to $2.3 million in 2025, then slumped by 700.35% to -$13.6 million in 2026.
  • Per Business Quant data, the three most recent Non Operating Income figures were -$13.6 million in Q1 2026, $2.3 million in Q4 2025, and $11.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -216.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 20.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -7.50 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 53.40 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 Alkermes 8.78 Bn 8.27 Bn 331.33 Mn -13.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.65 Mn
Dec 31, 2025 2.27 Mn
Sep 30, 2025 11.66 Mn
Jun 30, 2025 11.86 Mn
Mar 31, 2025 11.70 Mn
Dec 31, 2024 7.20 Mn
Sep 30, 2024 5.47 Mn
Jun 30, 2024 6.84 Mn
Mar 31, 2024 3.60 Mn
Dec 31, 2023 3.69 Mn
Sep 30, 2023 3.51 Mn
Jun 30, 2023 560,000.00
Mar 31, 2023 -361,000.00
Dec 31, 2022 -1.11 Mn
Sep 30, 2022 -6.73 Mn
Jun 30, 2022 1.21 Mn
Mar 31, 2022 -18.41 Mn
Dec 31, 2021 -2.16 Mn
Sep 30, 2021 -6.88 Mn
Jun 30, 2021 1.23 Mn